AC Immune (ACIU) Asset Writedowns and Impairment (2018 - 2019)
AC Immune's (ACIU) quarterly Asset Writedowns and Impairment came in at -$3012.2 in Q1 2019, up 93.36% year-on-year from -$1557.8 in Q1 2018, and up 93.36% on a QoQ basis from -$45339.5 in Q1 2018.
AC Immune (ACIU) Asset Writedowns and Impairment (2018 - 2019) Analysis & Trends
AC Immune (ACIU) has 2 years of Asset Writedowns and Impairment data on file, last reported at -$3012.2 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -3,012.19 |
| Mar 31, 2019 | -3,012.19 |
| Mar 31, 2018 | -45,339.46 |
| Mar 31, 2018 | -45,339.46 |